Skip to main content

Research Repository

Advanced Search

Does flare trial design affect the effect size of non-steroidal anti-inflammatory drugs in symptomatic osteoarthritis? A systematic review and meta-analysis

Smith, Toby O.; Zou, Kun; Abdullah, Natasya; Chen, Xi; Kingsbury, Sarah R.; Doherty, Michael; Zhang, Weiya; Conaghan, Philip G.

Authors

Toby O. Smith

Kun Zou

Natasya Abdullah

Xi Chen

Sarah R. Kingsbury

Michael Doherty

Philip G. Conaghan



Abstract

Objectives: It is thought that the clinical trial benefits of oral non-steroidal anti-inflammatory drugs (NSAIDs) may relate to flare designs. The aim of this study was to examine the difference in NSAID (including cyclooxygenase-2 (COX-2) inhibitors) response in osteoarthritis (OA) trials based on different designs.

Methods: Systematic review was undertaken of the databases MEDLINE, EMBASE, AMED, CINAHL and the Cochrane library till February 2015. Randomised controlled trials assessing pain, function and/or stiffness following commencement of NSAIDs in flare and non-flare designs were eligible. Trials were assessed using the Cochrane Risk of Bias tool. Meta-analyses were conducted to assess the effect sizes (ES) of NSAIDs for OA with flare versus non-flare trial designs.

Results: Fifty-seven studies including 33 263 participants assessing 26 NSAIDs were included. Twenty-two (39%) were flare design, 24 (42%) were non-flare designs, 11 (19%) were possible flare designs. On meta-analysis, there was no statistically significant difference in ES of NSAIDs versus placebo between flare and non-flare trial designs for absolute pain and function or stiffness at immediate-term (1 week), short-term (2–4 week) or longer-term (12–13 week) follow-up periods (p>0.05). However there was a lower ES for mean change in pain in flare and possible flare trials compared with non-flare trials at short-term follow-up (0.36 vs 0.69; p=0.05).

Conclusions: Contrary to previous understanding, flare trial designs do not result in an increased treatment effect for NSAIDs in people with OA compared with non-flare design. Whether flare design influences other outcomes such as joint effusion remains unknown.

Journal Article Type Article
Acceptance Date Jan 23, 2016
Publication Date Feb 18, 2016
Deposit Date Apr 17, 2018
Print ISSN 0003-4967
Electronic ISSN 1468-2060
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Volume 75
Issue 11
DOI https://doi.org/10.1136/annrheumdis-2015-208823
Public URL https://nottingham-repository.worktribe.com/output/1126433
Publisher URL https://ard.bmj.com/content/75/11/1971
PMID 26882928